Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1956 2
1957 2
1959 1
1962 3
1963 6
1964 6
1965 2
1966 6
1967 8
1968 3
1969 11
1970 11
1971 17
1972 7
1973 6
1974 9
1975 2
1976 14
1977 14
1978 13
1979 20
1980 21
1981 28
1982 18
1983 37
1984 28
1985 31
1986 25
1987 37
1988 30
1989 29
1990 45
1991 39
1992 41
1993 37
1994 40
1995 67
1996 75
1997 90
1998 70
1999 51
2000 79
2001 88
2002 76
2003 99
2004 101
2005 92
2006 90
2007 88
2008 90
2009 120
2010 130
2011 137
2012 169
2013 151
2014 157
2015 159
2016 154
2017 157
2018 184
2019 181
2020 232
2021 249
2022 243
2023 181
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3,992 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: ishii h. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
MicroRNA expression profiling in acute kidney injury.
Aomatsu A, Kaneko S, Yanai K, Ishii H, Ito K, Hirai K, Ookawara S, Kobayashi Y, Sanui M, Morishita Y. Aomatsu A, et al. Among authors: ishii h. Transl Res. 2022 Jun;244:1-31. doi: 10.1016/j.trsl.2021.11.010. Epub 2021 Dec 4. Transl Res. 2022. PMID: 34871811 Free article.
Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma.
Chijimatsu R, Kobayashi S, Takeda Y, Kitakaze M, Tatekawa S, Arao Y, Nakayama M, Tachibana N, Saito T, Ennishi D, Tomida S, Sasaki K, Yamada D, Tomimaru Y, Takahashi H, Okuzaki D, Motooka D, Ohshiro T, Taniguchi M, Suzuki Y, Ogawa K, Mori M, Doki Y, Eguchi H, Ishii H. Chijimatsu R, et al. Among authors: ishii h. iScience. 2022 Jun 22;25(8):104659. doi: 10.1016/j.isci.2022.104659. eCollection 2022 Aug 19. iScience. 2022. PMID: 35847558 Free PMC article.
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, Muramatsu T, Ishii H, Kozuma K, Tanaka N, Matsuo H, Uemura S, Kadota K, Hikichi Y, Tsujita K, Ako J, Nakagawa Y, Morino Y, Hamanaka I, Shiode N, Shite J, Honye J, Matsubara T, Kawai K, Igarashi Y, Okamura A, Ogawa T, Shibata Y, Tsuji T, Yajima J, Iwabuchi K, Komatsu N, Sugano T, Yamaki M, Yamada S, Hirase H, Miyashita Y, Yoshimachi F, Kobayashi M, Aoki J, Oda H, Katahira Y, Ueda K, Nishino M, Nakao K, Michishita I, Ueno T, Inohara T, Kohsaka S, Ismail TF, Serruys PW, Nakamura M, Yokoi H, Ikari Y; Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT). Ozaki Y, et al. Among authors: ishii h. Cardiovasc Interv Ther. 2022 Jan;37(1):1-34. doi: 10.1007/s12928-021-00829-9. Epub 2022 Jan 12. Cardiovasc Interv Ther. 2022. PMID: 35018605 Free PMC article. Review.
Tuberculous peritonitis.
Kushima H, Sakamoto R, Kinoshita Y, Ishii H. Kushima H, et al. Among authors: ishii h. BMJ Case Rep. 2021 Oct 1;14(10):e245311. doi: 10.1136/bcr-2021-245311. BMJ Case Rep. 2021. PMID: 34598967 Free PMC article. No abstract available.
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Ozaka M, et al. Among authors: ishii h. Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36652891 Free article. Clinical Trial.
Idiopathic pleuroparenchymal fibroelastosis.
Kinoshita Y, Kushima H, Ishii H. Kinoshita Y, et al. Among authors: ishii h. BMJ Case Rep. 2022 Jul 5;15(7):e251483. doi: 10.1136/bcr-2022-251483. BMJ Case Rep. 2022. PMID: 35790325 No abstract available.
Detection techniques for epitranscriptomic marks.
Ofusa K, Chijimatsu R, Ishii H. Ofusa K, et al. Among authors: ishii h. Am J Physiol Cell Physiol. 2022 Apr 1;322(4):C787-C793. doi: 10.1152/ajpcell.00460.2021. Epub 2022 Mar 16. Am J Physiol Cell Physiol. 2022. PMID: 35294846 Free article. Review.
Pancreatic Cancer Research beyond DNA Mutations.
Sato H, Sasaki K, Hara T, Tsuji Y, Arao Y, Otsuka C, Hamano Y, Ogita M, Kobayashi S, di Luccio E, Hirotsu T, Doki Y, Eguchi H, Satoh T, Uchida S, Ishii H. Sato H, et al. Among authors: ishii h. Biomolecules. 2022 Oct 17;12(10):1503. doi: 10.3390/biom12101503. Biomolecules. 2022. PMID: 36291712 Free PMC article. Review.
3,992 results